Literature DB >> 8054911

Graft failure after bone marrow transplantation from unrelated donors using busulphan and cyclophosphamide for conditioning.

J Mehta1, R L Powles, P Mitchell, K Rege, C De Lord, J Treleaven.   

Abstract

Five patients received bone marrow allografts for leukaemia from serologically fully matched unrelated donors. The conditioning regimen was busulphan 16 mg/kg and cyclophosphamide (CY) 120 mg/kg. Engraftment was achieved in only two patients, with primary graft failure occurring in three patients. Two of the three patients with no evidence of myeloid engraftment on day 28 received GM-CSF without response. Both these patients required rescue with cryopreserved autologous material. Three patients remain alive, one died of relapse after a successful allograft and one died with pancytopenia. Although the number of patients is small, we conclude that the BuCY2 regimen with 120 mg/kg CY, while adequate for sibling allografts, may not be sufficiently immunosuppressive to permit consistent engraftment of bone marrow from unrelated donors.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8054911

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  3 in total

Review 1.  Bone marrow transplantation using unrelated donors for haematological malignancies.

Authors:  O Ringdén
Journal:  Med Oncol       Date:  1997-03       Impact factor: 3.064

2.  Does Total Body Irradiation Have a Favorable Impact on Thrombocyte Engraftment as per Neutrophil Engraftment in Allogeneic Stem Cell Transplantation?

Authors:  Bahar Uncu Ulu; Tuğçe Nur Yiğenoğlu; Derya Şahin; Semih Başcı; Dicle İskender; Yasemin Adaş; Ebru Atasever Akkaş; Tuba Hacıbekiroğlu; Merih Kızıl Çakar; Mehmet Sinan Dal; Fevzi Altuntaş
Journal:  Cureus       Date:  2021-11-11

3.  Autologous Hematopoietic Recovery after Unrelated Umbilical Cord Blood Transplantation with Myeloablative Conditioning for Acute Myelogenous Leukemia.

Authors:  Ayumi Gomyo; Hideki Nakasone; Hidenori Wada; Shunto Kawamura; Nozomu Yoshino; Junko Takeshita; Kazuki Yoshimura; Yukiko Misaki; Aki Tanihara; Yu Akahoshi; Machiko Kusuda; Masaharu Tamaki; Koji Kawamura; Shun-Ichi Kimura; Shinichi Kako; Yoshinobu Kanda
Journal:  Intern Med       Date:  2020-06-15       Impact factor: 1.271

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.